Ascendis

Biotech’s near-term key catalysts
Biotech’s near-term key catalysts
EP Vantage
Biogen
Eisai
Alzheimer's disease
Arrowhead Pharmaceuticals
Takeda
RNAi
Madrigal
NASH
Ascendis
FDA
Flag link:
FDA pushes back Ascendis' PDUFA for long-acting hormone therapy
FDA pushes back Ascendis' PDUFA for long-acting hormone therapy
Endpoints
Ascendis
FDA
pediatric growth hormone deficiency
Flag link:
5 Biotech Stocks Set to Beat Q3 Earnings Estimates
5 Biotech Stocks Set to Beat Q3 Earnings Estimates
Yahoo/Zacks.com
earnings
biotech
Eyenovia
SAGE Therapeutics
AC Immune
Ascendis
NGM Biopharmaceuticals
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
Yahoo/Benzinga
FDA
Novartis
Ascendis
Eiger BioPharmaceuticals
Proteostasis Therapeutics
Fibrocell Science
Supernus Pharmaceuticals
FibroGen
INSYS Therapeutics
Flag link:
Ascendis jumps on Phase III readout for once-weekly growth hormone
Ascendis jumps on Phase III readout for once-weekly growth hormone
BioCentury
Ascendis
TransCon hGH
pediatric growth hormone deficiency
clinical trials
Flag link:
Upcoming events – Ascendis and Lilly hope for growth with pivotal data
Upcoming events – Ascendis and Lilly hope for growth with pivotal data
EP Vantage
Ascendis
clinical trials
pediatric growth hormone deficiency
TransCon hGH
Eli Lilly
olumiant
eczema
Flag link:
Last Week's Biotech IPO Recap
Last Week's Biotech IPO Recap
Yahoo/Benzinga
biotech
IPOs
Zosano
Ascendis
Presbia
Flex Pharma
Entellus Medical
Spark Therapeutics
TRACON Pharmaceuticals
Avinger
Flag link:
4 More Biotech IPOs Going Public This Week
4 More Biotech IPOs Going Public This Week
Yahoo/Benzinga
IPOs
biotech
Ascendis
EyeGate Pharma
Entellus Medical
Flex Pharma
Flag link:
Novo Nordisk, Lilly, Novartis Said to Bid for Ascendis Pharma
Novo Nordisk, Lilly, Novartis Said to Bid for Ascendis Pharma
Bloomberg Businessweek
Novo Nordisk
Eli Lilly
Novartis
Ascendis
M&A
Flag link: